treatment psoriasi piritrexim lipid-solubl folat antagonist methotrex effect conveni treatment sever psoriasi use develop hepat fibrosi cirrhosi small number patient mechan hepatotox unknown result intracellular polyglutam prolong retent methotrex cell piritrexim isethion lipid-solubl antifol mechan action similar methotrex piritrexim effect treatment psoriasi long-term hepatotox phase i/ii clinic trial sever chronic plaqu psoriasi safeti efficaci oral piritrexim therapi experi oncolog trial patient twice-daili dosag consecut day week dosag mg day improv lesion score percentag bodi involv signific dose mg twice fifteen patient week therapi improv lesion score improv recrudesc lesion rest period advers experi minim dose piritrexim efficaci treatment psoriasi 